NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-337-2004-0-AU-10 Recombinant MVA Viruses Expressing Clade A/G, Clade B, and C Modified HIV Env, Gag, And Pol Genes AU DIV 2012202786 Expired
NIA E-084-2011-1-PCT-02 COMPOSITIONS AND METHODS FOR INCREASING THE FREQUENCY OF HOMOLOGUS RECOMBINATION PCT PCT PCT/US2012/037650 Expired
NIA E-103-2011-2-PCT-01 USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS PCT PCT COMB PCT/US2012/037643 Expired
NHLBI E-249-2006-2-US-04 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device US DIV 13/468,761 9271833 Issued PDF
NCI E-081-2011-0-PCT-02 Tropolone Compounds For Treating Or Preventing Retroviral Infection PCT PCT PCT/US2012/037208 Expired
NIAID E-006-2010-1-US-02 Protection Against Pandemic and Seasonal Strains Of Influenza US National Stage 13/500,421 Abandoned
NIA E-260-2011-0-US-01 SYNTHESIS OF FLUOROARACHIDONIC AND METHODS OF USE THEREOF US 61/644,970 Abandoned
NIDCR E-038-2013-1-US-01 SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH13/466473 US CIP 13/466,473 8921340 Issued PDF
NCI E-117-2011-0-IN-29 Recombinant Immunotoxin Targeting Mesothelin IN National Stage 8854/CHENP/2013 Abandoned
NCI E-117-2011-0-EP-09 Recombinant Immunotoxin Targeting Mesothelin EP National Stage 12722586.0 Issued
NCI E-117-2011-0-JP-23 Recombinant Immunotoxin Targeting Mesothelin JP National Stage 2014-509467 Issued
NCI E-117-2011-0-AU-03 Recombinant Immunotoxin Targeting Mesothelin AU National Stage 2012253896 Issued
NCI E-117-2011-0-CN-24 Recombinant Immunotoxin Targeting Mesothelin CN National Stage 201280033583.7 Issued
NIAID E-131-2002-0-US-20 Methods of Treating and Preventing Colitis Involving IL-13 and NK-T Cells US DIV 13/464,323 8821866 Abandoned PDF
NCI E-117-2011-0-PCT-02 Recombinant Immunotoxin Targeting Mesothelin PCT PCT PCT/US2012/036456 Expired
NCI E-117-2011-0-KR-11 Recombinant Immunotoxin Targeting Mesothelin KR National Stage 10-2013-7032247 Abandoned
NCI E-117-2011-0-CL-06 Recombinant Immunotoxin Targeting Mesothelin CL National Stage 03182-2013 Abandoned
NCI E-117-2011-0-ID-27 Recombinant Immunotoxin Targeting Mesothelin ID National Stage W-00201305198 Abandoned
NCI E-117-2011-0-IL-28 Recombinant Immunotoxin Targeting Mesothelin IL National Stage 229198 Abandoned
NCI E-117-2011-0-MX-12 Recombinant Immunotoxin Targeting Mesothelin MX National Stage MX/a/2013/012905 Abandoned
NCI E-117-2011-0-PH-15 Recombinant Immunotoxin Targeting Mesothelin PH National Stage 1-2013-502264 Abandoned
NCI E-117-2011-0-SG-17 Recombinant Immunotoxin Targeting Mesothelin SG National Stage 201308179-9 Abandoned
NCI E-117-2011-0-EC-07 Recombinant Immunotoxin Targeting Mesothelin EC National Stage SP-13-13067 Abandoned
NCI E-117-2011-0-MY-13 Recombinant Immunotoxin Targeting Mesothelin MY National Stage PI 2013702094 Abandoned
NCI E-117-2011-0-CR-26 Recombinant Immunotoxin Targeting Mesothelin CR National Stage 2013-0571 Abandoned
NCI E-117-2011-0-CO-25 Recombinant Immunotoxin Targeting Mesothelin CO National Stage 13-274.153 Abandoned
NCI E-117-2011-0-TH-18 Recombinant Immunotoxin Targeting Mesothelin TH National Stage 1301006329 Abandoned
NCI E-117-2011-0-UA-19 Recombinant Immunotoxin Targeting Mesothelin UA National Stage 201313011 Abandoned
NCI E-117-2011-0-BR-04 Recombinant Immunotoxin Targeting Mesothelin BR National Stage 112013028537-0 Abandoned
NCI E-117-2011-0-DZ-31 Recombinant Immunotoxin Targeting Mesothelin DZ National Stage 2058-07-13 Abandoned
NCATS E-072-2012-0-US-01 Modulators Of The Relaxin Receptor 1 US 61/642,986 Abandoned
NCI E-077-2012-0-US-01 Use Of CPG Oligonucleotides To Inhibit Chemotherapy Induced Pneumonitis US 61/643,088 Abandoned
NCI E-117-2011-0-VN-20 Recombinant Immunotoxin Targeting Mesothelin VN National Stage 1-2013-03855 Abandoned
CC E-198-2011-0-US-01 Imaging Thermometry US 61/641,315 Abandoned
NIAID E-575-2013-1-US-01 VACCINE FOR FALCIPARUM MALARIA US 61/641,445 Abandoned
NIDA E-233-2012-0-US-01 HETEROCYCLE-FUSED MORPHINANS, USE THEREOF AND PREPARATION THEREOF US 61/641,355 Abandoned
NINDS E-225-2009-0-US-03 Composition and Methods for the Treatment or Prevention of Mitochondrial Diseases US National Stage 13/460,852 Abandoned
NCI E-074-2007-0-US-10 Brachyury Polypeptides And Methods For Use US CON 13/460,587 8613933 Issued PDF
NHLBI E-126-2011-0-PCT-02 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS PCT PCT PCT/ US12/35870 Expired
NHLBI E-126-2011-0-EP-05 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS EP National Stage 12726266.5 Abandoned
NHLBI E-126-2011-0-AU-03 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS AU National Stage 2012249301 Abandoned
NHLBI E-126-2011-0-CA-04 CHEMICAL MODIFICATION OF APOLIPOPROTEIN MIMETIC PEPTIDES FOR THE PRODUCTION OF THERAPEUTIC AGENTS CA National Stage 2834657 Abandoned
NIDCR E-233-2000-0-JP-09 Adult Human Dental Pulp Stem Cells In Vitro and In Vivo JP DIV 2012-103397 Expired
NCI E-294-2011-0-US-01 Use Of CpG Oligonucleotides Co-formulated With An Antibiotic To Accelerate Wound Healing US 61/639,688 Abandoned
NCI E-230-2011-0-US-01 Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US 61/639,230 Abandoned
NCI E-181-2006-0-FR-20 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer FR EP 12165734.0 Abandoned
NCI E-181-2006-0-IT-21 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer IT EP 12165734.0 Abandoned
NCI E-181-2006-0-ES-19 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer ES EP 12165734.0 Abandoned
NCI E-181-2006-0-ES-16 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer ES EP 12165748.0 Abandoned
NHLBI E-173-2009-0-CA-03 Selective Access To Cryopreserved Samples CA National Stage 2760363 Abandoned